caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1891805164

Guireida Rivera ColonMD

EndocrinologyJuana Diaz, PRI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
QUALITY · MIPS · 2024
No data available for this provider in 2024.
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$37
Payment records
2
By payment type
Food and Beverage$37
PRESCRIBING · PART D · 2024
Total Rx claims
13,798
Beneficiaries
—
Total drug cost
$1.5M
Distinct drugs
110
Brand share
45.6%
Top prescribed drugs
Levothyroxine Sodium1,964 claims
Rosuvastatin Calcium813 claims
Levothyroxine Sodium805 claims
Glimepiride520 claims
Atorvastatin Calcium425 claims
REFERRAL NETWORK

Where Guireida Rivera Colon's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 2 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
Cesar Trabanco
Endocrinology · Ponce, PR
1927
Laboratorio Clinico Irizarry Guasch Inc
Clinical Laboratory · Mayaguez, PR
1452
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
71
Unique beneficiaries
—
Total services
108
Distinct HCPCS
3
Medicare payment
$6K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 86 Endocrinology providers in PR — above median (cohort median 88).